Chess Therapeutics, LLC
Research - New York, New York, United States
Chess Therapeutics, LLC Employees
Chess Therapeutics, LLC Details
Chess Therapeutics is an oncology focused biotechnology company developing novel microtubule targeted drugs with a distinct spectrum of anti-cancer activity and pharmacologic properties compared with other microtubule targeted agents. The company's drug candidates effectively cross the blood-brain barrier, have potential for oral delivery, and exhibit a favorable toxicity profile. They demonstrate preferential and potent activity against the aggressive brain cancer glioblastoma and cancers that carry the "cancer driving" gene mutation BRAF (melanoma, colorectal cancer, lung adenocarcinoma).
Chess Therapeutics, LLC Technologies
Email Providers
Outlook
Advertising Networks
Google AdSense
Other
Mobile Friendly
Hosting
Google Cloud Hosting